$2.81
0[0.00%]
Last update: 4:00PM Get Real Time Here
Arbutus Biopharma
(NASDAQ:ABUS)Arbutus Biopharma Stock (NASDAQ:ABUS), Earnings Estimates, EPS, and Revenue
Arbutus Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 2
EPS
$-0.100
Quarterly Revenue
$1.5M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$13M
Analyze the earnings history of Arbutus Biopharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABUS | Arbutus Biopharma | -$0.10 | — | — | — | $4.65M | — | — | — | 08/01/2024 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.10 | -$0.11 | -$0.10 | 9.09% | $6.69M | $2.15M | $1.53M | -28.74% | 05/02/2024 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.14 | -$0.12 | -$0.12 | 0.00% | $6.25M | $4.79M | $2.15M | -55.22% | 02/29/2024 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.12 | -$0.11 | -$0.12 | -9.09% | $5.95M | $4.75M | $4.66M | -1.94% | 11/07/2023 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.10 | -$0.12 | -$0.10 | 16.67% | $14.24M | $5.02M | $4.65M | -7.35% | 08/03/2023 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.11 | -$0.14 | -$0.10 | 28.57% | $12.58M | $6.03M | $6.69M | 10.90% | 05/04/2023 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.15 | -$0.13 | -$0.14 | -7.69% | $3.21M | $6.17M | $6.25M | 1.22% | 03/02/2023 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.24 | -$0.13 | -$0.12 | 7.69% | $3.34M | $9.37M | $5.95M | -36.48% | 11/09/2022 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.23 | -$0.13 | -$0.10 | 23.08% | $2.33M | $6.77M | $14.24M | 110.35% | 08/04/2022 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.21 | -$0.16 | -$0.11 | 31.25% | $2.11M | $4.37M | $12.58M | 187.89% | 05/05/2022 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.23 | -$0.19 | -$0.15 | 21.05% | $2.39M | $2.87M | $3.21M | 11.71% | 03/03/2022 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.27 | -$0.24 | -$0.24 | 0.00% | $1.52M | $2.38M | $3.34M | 40.34% | 11/04/2021 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.25 | -$0.22 | -$0.23 | -4.55% | $1.51M | $2.12M | $2.33M | 9.86% | 08/05/2021 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.25 | -$0.23 | -$0.21 | 8.70% | $1.49M | $3.31M | $2.11M | -36.16% | 05/05/2021 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.46 | -$0.22 | -$0.23 | -4.55% | $1.62M | $1.96M | $2.39M | 21.73% | 03/04/2021 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.73 | -$0.22 | -$0.27 | -22.73% | $3.10M | $1.66M | $1.52M | -8.25% | 11/05/2020 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.46 | -$0.24 | -$0.25 | -4.17% | $700.00K | $1.74M | $1.51M | -12.99% | 08/07/2020 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.47 | -$0.39 | -$0.25 | 35.90% | $700.00K | $220.00K | $1.49M | 577.73% | 05/11/2020 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.37 | -$0.39 | -$0.46 | -17.95% | $1.60M | $220.00K | $1.62M | 635.45% | 03/05/2020 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.30 | — | -$0.73 | — | $1.60M | — | $3.10M | — | 11/06/2019 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.44 | -$0.39 | -$0.46 | -17.95% | $1.20M | $220.00K | $700.00K | 218.18% | 08/05/2019 | Get Alert |
FAQ
When is Arbutus Biopharma (NASDAQ:ABUS) reporting earnings?
Arbutus Biopharma (ABUS) is scheduled to report earnings on August 1, 2024. The last reported earnings were for reported on May 2, 2024 for Q1.
What were the latest earnings per share (EPS) for Arbutus Biopharma (NASDAQ:ABUS)?
The Actual EPS was $-0.10, which beat the estimate of $-0.11.
What were Arbutus Biopharma’s (NASDAQ:ABUS) revenues?
The Actual Revenue was $1.5M, which missed the estimate of $2.1M.
Browse earnings estimates, EPS, and revenue on all stocks.